September 30, 2013 Astex Pharmaceuticals Announces Oral Presentation of SGI-110 AML Data at the European Cancer Congress DUBLIN, Calif., Sept. 30, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a ph

Source URL: astx.com

• Biomarker
• Medicine
• Astex
• Acute myeloid leukemia

Astex Pharmaceuticals to Announce 2011 Fourth Quarter and Year-End Financial Results on March 5, 2012 DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the

Source URL: astx.com

July 29, 2013 Astex Pharmaceuticals to Announce 2013 Second Quarter Financial Results on August 1st DUBLIN, Calif., July 29, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company d

Source URL: astx.com

Astex Receives Milestone from Wellcome Trust for Pioneering HCV Research Cambridge, UK, 1st February 2011 Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, an

Source URL: astx.com

• Health in the United Kingdom
• Science and technology in the United Kingdom
• Cambridge Science Park
• Hepatitis C virus
• Wellcome Trust
• Hepatitis C
• Medical research
• United Kingdom
• Astex
• Health

News Release Astex Pharmaceuticals Reports 2012 Second Quarter Financial Results Dacogen Royalty Revenue Increased 25% from Prior Year $5.4 Million Earned on Phase I Trial Initiation of FGFR Kinase Inhibitor Dacogen Rece

Source URL: astx.com

• Generally Accepted Accounting Principles
• Pharmacology
• Taxation
• Financial statements
• Pharmaceutical industry
• Astex
• Income tax in the United States
• Balance sheet
• Amortization
• Accountancy
• Business
• Finance

April 10, 2013 Astex Pharmaceuticals Provides SGI-110 Update Oral Presentation at AACR Supports Potential of SGI-110 In The Treatment Of Platinum-Resistant Ovarian Cancer Clinical Update on SGI[removed]Study DUBLIN, Cali

Source URL: astx.com

• Alkylating antineoplastic agents
• Acute leukemia
• Acute myeloid leukemia
• Myeloid leukemia
• Myelodysplastic syndrome
• Carboplatin
• Chemistry
• Oncology
• Medicine

Astex Announces Milestone in Oncology Collaboration Cambridge, UK, 11 January 2011 Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, announced that it has rec

Source URL: astx.com

• Cell cycle
• Tumor suppressor genes
• Transcription factors
• Astex
• Cyclin-dependent kinase
• P16
• Retinoblastoma protein
• Cyclin
• Melanoma
• Biology
• Cell biology
• Proteins

September 6, 2012 Astex Pharmaceuticals, Cancer Research Technology and The Institute of Cancer Research Announce Epigenetic Drug Discovery Collaboration DUBLIN, Calif., and CAMBRIDGE, UK, Sept. 6, 2012 (GLOBE NEWSWIRE)

Source URL: astx.com

• Institute of Cancer Research
• Astex
• Cancer research
• Cancer Research UK
• American Association for Cancer Research
• Medicine
• Cancer organizations
• Oncology

Eisai Inc. Receives Complete Response Letter from the U.S. Food and Drug Administration for Dacogen® (decitabine) for Injection sNDA in Acute Myeloid Leukemia DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc

Source URL: astx.com

• Myelodysplastic syndrome
• Syndromes
• Acute myeloid leukemia
• Eisai
• Neutropenia
• Decitabine
• Anemia
• Medicine
• Oncology
• Health

Astex Pharmaceuticals Reports 2012 First Quarter Financial Results Reports First Quarter Net Income of $4.2 Million Dacogen Royalty Revenue Increases 21% from Prior Year Ends First Quarter with $126 Million in Cash & Mar

Source URL: astx.com

• Generally Accepted Accounting Principles
• Taxation
• Balance sheet
• Amortization
• Deferral
• Astex
• Income tax in the United States
• Goodwill
• Valuation
• Accountancy
• Finance
• Business